The record
Every study, in full.
Each study reports an effect index, a 95 percent credible interval, and a status. Null and in-progress results sit at equal prominence to validated ones, because absence is a finding.
Browse the studies, then enroll.
Every study below is open to read. To enroll and contribute your data, create a free account and build your profile first, that is how we match you to the studies you can join.
Self-reported recovery among current BPC-157 users
Observational, within-person, pre and post baseline
Illustrative onlyEffect
+0.38
95% CrI
0.16 to 0.59
n
386
Twelve-week recovery follow-up cohort
Observational, longitudinal, repeated self-report
Illustrative onlyEffect
+0.41
95% CrI
0.19 to 0.62
n
211
Appetite-regulation subgroup analysis
Observational, pre-specified subgroup
Illustrative onlyEffect
+0.57
95% CrI
0.39 to 0.74
n
540
Self-reported metabolic outcomes among current GLP-1 users
Observational, within-person, pre and post baseline
Illustrative onlyEffect
+0.61
95% CrI
0.44 to 0.77
n
1240
Arousal pilot cohort
Observational, pilot, self-report
Illustrative onlyEffect
+0.24
95% CrI
0.00 to 0.49
n
76
Self-reported libido outcomes among current PT-141 users
Observational, within-person, pre and post baseline
Illustrative onlyEffect
+0.29
95% CrI
0.04 to 0.52
n
198
Self-reported cognitive outcomes among current Selank users
Observational, within-person, pre and post baseline
Illustrative onlyEffect
+0.06
95% CrI
0.00 to 0.19
n
64
Founding access
See every study, in full.
Create your free account to open the complete record: every effect index, credible interval, and null result, tuned to the goals you set.